NL Industries (NL) stock prices updated...
 

NL Industries stock price

NL Industries latest news:


  • 08/18/2017 11:41:25

    BRIEF-Teva announces exclusive launch of generic Axiron® in United States

    Teva Pharmaceutical Industries Ltd(TEVA) : * Teva announces exclusive launch of generic Axiron® in the United States. * Teva Pharmaceutical Industries Ltd (TEVA) says launch of generic Axiron topical solution CIII, 30 mg/1.5 ml, in U.S. Source text for Eikon: Further company coverage:

  • 08/17/2017 10:59:47

    Reps. Cummings, Welch to launch investigation into multiple sclerosis drug prices

    Rep. Elijah Cummings (D-Md.) and Rep. Peter Welch (D-Vt.) said Thursday morning that they are launching an investigation into multiple sclerosis drug prices, and have sent letters to seven pharmaceutical companies about their pricing strategies. Letters were sent to Bayer AG , Biogen Inc. , Merck & Co.'s EMD Serono, Novartis AG , Sanofi SA , Teva Pharmaceutical Industries Ltd. and Roche Holding AG . Biogen shares declined 2.9% in heavy midday trade and Teva shares declined 1.1% in moderate trade. The lawmakers asked for information to evaluate multiple sclerosis drugs' "substantial price increases, including information about corporate profits and expenses and documents concerning pricing strategies, patient assistance programs, and drug distribution systems," and requested a response by the end of the month. The average price of a multiple sclerosis disease-modifying therapy rose from $16,000 in 2004 to about $84,000 in 2017, according to the National Multiple Sclerosis Society (the numbers refer to average wholesale price, which does not reflect often-substantial discounts and rebates). Prices for drugs sold by the seven drugmakers have increased by as much as 1,002% since 2012, according to information from the National Multiple Sclerosis Society cited by the two representatives. The lawmakers said that their letter referred to an American Academy of Neurology study that found "some drug companies appear to be increasing their prices and setting new, higher prices in lockstep in competitors," which may reflect a phenomenon called "shadow pricing" in which companies respond to eachothers' price increases. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/16/2017 12:20:37

    In Trump's Government, The 'Regulated Have Become The Regulators'

    Eric Lipton of The New York Times says lobbyists now working for the government are leading a regulatory roll back that is benefiting the industries they used to represent.

  • 08/15/2017 17:49:57

    BRIEF-Flexsteel Industries Q4 earnings per share $0.76

    * During fiscal year 2018, the company anticipates spending $5 million for capital expenditures Source text for Eikon: Further company coverage:

  • 08/15/2017 15:15:25

    BRIEF-Nacco Industries and co's unit enters amended, restated credit agreement

    * Nacco Industries-on Aug 11, co's unit entered amended, restated credit agreement for a 5-year, $150 million unsecured revolving line of credit Source text: (http://bit.ly/2i3Zkfo) Further company coverage:

  • 08/15/2017 14:46:37

    BRIEF-Air Industries Group files for non-timely 10-Q - SEC filing‍​

    * Air Industries Group files for non-timely 10-Q - SEC filing‍​ Source text : (http://bit.ly/2i3Ce8J) Further company coverage:

  • 08/15/2017 10:19:08

    UPDATE 1-Shipbuilder Huntington Ingalls to pay $9.2 mln over false claims case

    WASHINGTON, Aug 15 (Reuters) - Defense contractor Huntington Ingalls Industries Inc will pay $9.2 million to settle civil charges that it violated the False Claims Act by overbilling for labor on U.S. Navy and Coast Guard ships, the U.S. Justice Department said Tuesday.

  • 08/14/2017 15:26:44

    Tepper's Appaloosa dumps Snap Inc., stake, loads up on tech, health care

    David Tepper's hedge fund Appaloosa Management unloaded its position in Snapchat-parent Snap Inc., and disclosed increases in the tech and health-care sectors at the end of the second quarter. As of June 30, Tepper's fund showed that his fund dumped 100,000 shares of of Snap Inc. , which has lost more than a third of its value since it debuted as a public entity in early March. Tepper had been one of a number of prominent investors who had vocally expressed support of the social-messaging company. On Monday, Snap's shares were among the most active, gaining about 6.5% to start the week. Elsewhere, Appaloosa showed new positions in the PowerShares QQQ Trust Series 1 , which mimics the technology laden Nasdaq-100 , purchasing 1.8 million shares of the so-called QQQs, valued at $249 million, representing about 3.7% of his overall portfolio, according to data from research provider Whalewisdom.com. The fund also more than doubled its Apple Inc. position to 625,000 shares worth about $90 million and those of Altaba Inc. , which he boosted to 5.1 million shares valued at $280 million. Appaloosa showed a fresh stake in Alibaba Group Holding Limited , scooping up 3.6 million shares worth $520 million. Tepper's investment vehicle added a new position in exchange-traded IBB , a prominent ETF tracking the biotech sector, and SPDR S&P Biotech ETF , which closely mimics the S&P 500's health-care sector. Tepper's firm bought 235,000 shares of IBB worth about $73 million and 330,000 shares of XBI valued at $34 million, as of the end of June. In other sales, Tepper & Co. unloaded all of its position in Teva Pharmaceutical Industries , Energy Transfer Partners L.P. and Pfizer Inc. among others. Related: Active-managers have a new favorite toolMarket Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/14/2017 15:14:19

    Tepper's Appaloosa dumps Snap Inc. stake, loads up on tech, health care

    David Tepper's hedge fund Appaloosa Management unloaded its position in Snapchat-parent Snap Inc., and disclosed increases in the tech and health-care sectors at the end of the second quarter. As of June 30, Tepper's fund showed that his fund dumped 100,000 shares of of Snap Inc. , which has lost more than a third of its value since it debuted as a public entity in early March. Tepper had been one of a number of prominent investors who had vocally expressed support of the social-messaging company. On Monday, Snap's shares were among the most active, gaining about 6.5% to start the week. Elsewhere, Appaloosa showed new positions in the PowerShares QQQ Trust Series 1 , which mimics the technology laden Nasdaq-100 , purchasing 1.8 million shares of the so-called QQQs, valued at $249 million, representing about 3.7% of his overall portfolio, according to data from research provider Whalewisdom.com. The fund also more than doubled its Apple Inc. position to 625,000 shares worth about $90 million and those of Altaba Inc. , which he boosted to 5.1 million shares valued at $280 million. Appaloosa showed a fresh stake in Alibaba Group Holding Limited , scooping up 3.6 million shares worth $520 million. Tepper's investment vehicle added a new position in exchange-traded IBB , a prominent ETF tracking the biotech sector, and SPDR S&P Biotech ETF , which closely mimics the S&P 500's health-care sector. Tepper's firm bought 235,000 shares of IBB worth about $73 million and 330,000 shares of XBI valued at $34 million, as of the end of June. In other sales, Tepper & Co. unloaded all of its position in Teva Pharmaceutical Industries , Energy Transfer Partners L.P. and Pfizer Inc. among others.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/14/2017 14:53:51

    BRIEF-Buhler Industries qtrly ‍shr $0.10​

    Buhler Industries Inc(BIIAF). * Buhler Industries(BIIAF) reports 3rd quarter earnings. * Q3 revenue c$91.4 million. * Qtrly ‍shr $0.10​. * Buhler Industries Inc (BIIAF) - sales for 2017 are expected to be up over 2016 sales.

  • 08/14/2017 14:27:39

    BRIEF-Forward Industries Q3 earnings per share $0.06

    Forward Industries Inc(FORD). * Forward reports fiscal 2017 third quarter results. * Q3 earnings per share $0.06. * Q3 revenue $7.3 million Source text for Eikon: Further company coverage:

  • 08/09/2017 15:19:25

    BRIEF-SIFCO Industries reports quarterly loss per share $1.13‍​

    * SIFCO Industries Inc - net sales from operations in q3 fiscal 2017 decreased 2.7% to $30.2 million, versus $31.0 million in the third quarter of fiscal 2016‍​ Source text for Eikon: [Id: nBw5Q0ch0a] Further company coverage:

  • 08/08/2017 09:48:18

    Polaris recalls ATVs for crash hazard less than a month after a recall for fire hazard

    Polaris Industries Inc. said Tuesday it was recalling 2,800 Scrambler XP 1000 all-terrain vehicles, model years 2014 through 2017, for a "crash hazard." The company said the recall notice comes after it received nine reports of the throttle release switch failing, including two "minor injuries." The ATVs in question were made in the U.S. by Polaris, and sold at Polaris dealers nationwide from April 2013 through June 2017 for about $13,300. This recall comes just three weeks after the company recalled 25,600 Sportsman 570 ATVs after reports of fuel leaks and fires. Polaris's stock fell 0.5% in midday trade. It has gained 8.0% year to date, while the S&P 500 has climbed 11%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/07/2017 10:10:36

    Teva's stock keeps plunging on heavy volume after Morgan Stanley downgrade

    Shares of Teva Pharmaceutical Industries Ltd. tumbled 8% in morning trade Monday on heavy volume, putting them on track to close at a 14-year low, as Morgan Stanley turned bearish on the generic drug maker in the aftermath of disappointing results. Volume ballooned to 39.1 million shares, which was more than triple the full-day average, and enough to make it the most actively traded stock on the major U.S. exchanges. The stock was headed for an eighth straight loss to the lowest close since March 13, 2003, highlighted by 39% plunge the past three sessions after the company missed profit expectations and cut its outlook, citing accelerated price erosion and decreased volume in its U.S. generics business. On Monday, Morgan Stanley analyst David Risinger cut his rating to underweight from equal weight, and slashed his stock price target to $16 from $36, saying he had underappreciated the risk of generics pricing pressure to Teva's earnings. The stock has plummeted 48% year to date, while the SPDR S&P Pharmaceuticals ETF has gained 5.9% and the S&P 500 has advanced 11%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/04/2017 15:09:10

    BRIEF-Mohawk Industries files for potential mixed shelf, undisclosed size - SEC filing‍​

    Mohawk Industries Inc(MHK). * Files for potential mixed shelf offering; size not disclosed - SEC filing‍​ Source text: Further company coverage:

  • 08/03/2017 14:33:46

    Teva and 3D Systems slide while Kellogg and Tesla jump

    Teva Pharmaceutical Industries and 3D Systems tumble while Kellogg and Tesla trade higher

  • 08/03/2017 09:12:21

    Teva's stock plunges on heavy volume after profit miss and slashed outlook

    Shares of Teva Pharmaceuticals Industries Ltd. plunged 10.4% in active premarket trade Thursday, after the drug maker missed fiscal second-quarter profit expectations and slashed its full-year outlook. Volume of 1.5 million shares made the stock the most actively traded ahead of the open. The net loss for the quarter to June 30 was $6.04 billion, or $5.94 a share, after a profit of $188 million, or 20 cents a share, in the same period a year ago.

  • 08/03/2017 09:12:21

    AmerisourceBergen stock plummets 9% alongside other companies affected by negative generic price trends

    AmerisourceBergen Corp.(ABC) shares plummeted 9% in extremely heavy morning trade Thursday after the company reported third-quarter profit beat but revenue miss. Shares of the drug distributor fell alongside other companies affected by generic price deflation on Thursday, after Teva Pharmaceutical Industries Ltd. (TEVA) reported generics revenue that was below expectations and cut its 2017 adjusted EPS outlook. AmerisourceBergen (ABC) said on its earnings call that generic...

  • 08/01/2017 15:54:53

    BRIEF-Flotek Industries files for mixed shelf of upto $350 mln

    * Flotek Industries Inc files for mixed shelf of upto $350 million - SEC filing Source text: (http://bit.ly/2vgTZXu) Further company coverage:

  • 08/01/2017 15:49:55

    BRIEF-Flotek Industries ‍adj EPS from continuing operations was $0.02/shr

    * Flotek Industries Inc - qtrly ‍revenue expanded 7 pct sequentially to $85.2 million and up 33 pct year-over-year​

  • 07/27/2017 09:41:57

    BRIEF-Tootsie roll industries Q2 sales $104.9 million versus $104.3 million

    Tootsie Roll Industries Inc(TR). * Q2 sales $104.9 million versus $104.3 million. * Qtrly earnings per share $0.19. * Q2 net earnings benefited from lower effective income tax rate, but were adversely affected by unfavorable foreign exchange Further company coverage:

  • 07/26/2017 15:59:57

    BRIEF-San Francisco expands its zero-emission footprint with an order for 185 trolley-electric buses

    * New Flyer Industries Inc - SFMTA has awarded an option order for 185 Xcelsior(®) trolley-electric, forty-foot, heavy-duty buses Source text for Eikon: Further company coverage:

  • 07/25/2017 22:31:57

    BRIEF-Praj Industries says Praj-Gevo joint development deal to enter commercialization phase

    * Says Praj-Gevo joint development agreement to enter commercialization phase

  • 07/20/2017 15:22:08

    PPG and C.H. Robinson slip while Abbott and Sears advance

    PPG Industries and C.H. Robinson Worldwide fall while Abbott Laboratories and Sears Holdings gain ground

  • 07/20/2017 09:03:33

    BRIEF-PPG approves 13 pct dividend increase to 45 cents per share

    PPG Industries Inc(PPG) : * PPG directors approve 13-percent dividend increase to 45 cents per share Source text for Eikon: Further company coverage:

  • 07/19/2017 12:48:14

    Polaris recalls tens of thousands of ATVs after reports of fire, fuel leaks

    Recreational vehicles company Polaris Industries Inc. recalled about 25,600 all-terrain vehicles (ATVs) after reports of fuel leaks and fires. The recall involves 2014 Sportsman 570 model ATVs sold from April 2014 through May 2017 for $6,500 to $7,700 in several colors, which were made by Polaris in the U.S., according to the Consumer Product Safety Commission. The recall follows 30 reports of fuel leaks and four incidents involving a fire, although no injuries had been reported. "Consumers should immediately stop using the recalled ATVs and contact Polaris to schedule a free repair," the company said in a statement. "Polaris is contacting all known purchasers directly." The stock, which was up 1.2% in afternoon trade, has rallied 12.9% year to date, while the S&P 500 has gained 10.4%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/17/2017 14:40:19

    BRIEF-CCA Industries reports qtrly earnings per share $0.10

    * Qtrly revenues $6.12 million versus $5.7 million Source text for Eikon: Further company coverage:

  • 07/17/2017 10:50:10

    What's in Store for PPG Industries (PPG) in Q2 Earnings?

    PPG Industries Inc PPG is set to release second quarter 2017 results ahead of the bell on Jul 20 In the last quarter PPG Industries reported adjusted earnings of 1 35 per share up 6 3 from the year ago figure Earnings beat the Zacks Consensus Estimate of 1 31 per share Net sales

  • 07/14/2017 14:28:06

    BRIEF-Schmitt Industries' Q4 sales $3.65 million

    Schmitt Industries Inc(SMIT). * Quarterly sales rose 22.5 percent to $3.65 million. * Quarterly loss per share $0.14 Source text for Eikon: Further company coverage:

  • 07/12/2017 13:18:57

    AstraZeneca's CEO Soriot to join Israeli drugs company Teva-report

    Israel-based Teva Pharmaceutical Industries (TEVA) will name AstraZeneca (AZN) chief executive Pascal Soriot as its next CEO, the Calcalist financial news website said on Wednesday. Soriot has met with Teva representatives and expressed his agreement to serve as its next CEO.

  • More trends:

    Noah Holdings Ltd.NOAH | Noble CorporationNE | Noble Energy Inc.NBL | Nokia CorporationNOK | Nomura Holdings Inc ADRNMR | Noranda Aluminum Holding CorporationNOR | Nord Anglia EducationNORD | Nordic American Offshore LtdNAO | Nordic American Tankers LimitedNAT | NordstromJWN |